Ratio of plasma IL-13/TNF- ∝ and CXCL10/CCL17 predicts mepolizumab and omalizumab response in asthma better than eosinophil count or immunoglobulin E level
Article in Scientific Reports (May 2024)
The most recent citing publications are shown below. View all 35 publications that cite this research output on Dimensions.
A Roadmap for Using Causal Inference and Machine Learning to Personalize Asthma Medication Selection
Article in JMIR Medical Informatics (April 2024)
Suboptimal response to biologics in severe asthma - a marker of humoral immunodeficiencies
Article in The Journal of Allergy and Clinical Immunology In Practice (March 2024)